Antioxidant enzyme activities and lipid peroxides in the plasma of patients with benign prostatic hyperplasia or prostate cancer are not predictive

Dogru-Abbasoglu, Semra; AYKAC-TOKER, G; Kocak, Taner; UNLUER, E; Uysal, Mehmet

doi:10.1007/s004320050293

Antioxidant enzyme activities and lipid peroxides in the plasma of patients with benign prostatic hyperplasia or prostate cancer are not predictive

Atıf İçin Kopyala

Dogru-Abbasoglu S., AYKAC-TOKER G., Kocak T., UNLUER E., Uysal M. M.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, cilt.125, sa.7, ss.402-404, 1999 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 125 Sayı: 7
Basım Tarihi: 1999
Doi Numarası: 10.1007/s004320050293
Dergi Adı: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.402-404
İstanbul Üniversitesi Adresli: Evet

Özet

In this study, lipid peroxide and total sulfhydryl contents and activities of superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase (CAT) were investigated in the plasma of patients with benign prostatic hyperplasia (BPH) and prostate cancer. No significant change was found in lipid peroxidation or antioxidant systems in the plasma of patients with BPH and prostate cancer. The results indicate that evaluation of the prooxidant-antioxidant balance in the plasma of BPH and prostate cancer patients cannot be used as a marker to discriminate between these diseases.